|
December 20, 2019
|
Neoleukin Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
|
|
|
December 17, 2019
|
Neoleukin Therapeutics Announces Pricing of $75.0 Million Public Offering
|
|
|
December 17, 2019
|
Neoleukin Therapeutics Announces Proposed Public Offering of Common Stock
|
|
|
December 5, 2019
|
Neoleukin Therapeutics Announces Scientific Advisory Board
|
|
|
November 26, 2019
|
Neoleukin Therapeutics to Present at Piper Jaffray 31st Annual Healthcare Conference
|
|
|
November 13, 2019
|
Neoleukin Therapeutics Announces Corporate Update and Third Quarter 2019 Financial Results
|
|
|
September 19, 2019
|
Neoleukin Therapeutics Announces Additions to Management Team
|
|
|
September 5, 2019
|
Neoleukin Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
|
August 9, 2019
|
Neoleukin Therapeutics and Aquinox Pharmaceuticals Complete Merger Transaction
|
|
|
August 7, 2019
|
Neoleukin Therapeutics to Present at Canaccord Genuity 39th Annual Growth Conference
|
|
